Nanoporous Canister Technology for Environmental Sustainability and Food Preservation

Publication ID: 24-11857670_0002_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Nanoporous Canister Technology for Environmental Sustainability and Food Preservation,” Published Technical Disclosure No. 24-11857670_0002_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857670_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,670.

Summary of the Inventive Concept

This inventive concept leverages the core technology of the original implantable canister patent to address pressing environmental and food preservation challenges. By adapting the nanoporous structure and biotherapeutic agent delivery capabilities to new applications, this concept offers innovative solutions for air quality monitoring, crop yield improvement, water treatment, forest fire prevention, and food preservation.

Background and Problem Solved

The original patent focused on implantable devices for therapeutic agent delivery in humans. However, the limitations of the original patent's scope and application became apparent. This new inventive concept addresses the need for innovative solutions to tackle environmental and food-related challenges, which are critical to global sustainability and human well-being.

Detailed Description of the Inventive Concept

The nanoporous canister technology is adapted to various environmental and food preservation applications. In air quality monitoring, the canisters detect changes in air quality and release biotherapeutic agents to neutralize pollutants. For crop yield improvement, the canisters are implanted in soil to release agents promoting healthy plant growth. In water treatment, the canisters encapsulate and neutralize pollutants. For forest fire prevention, the canisters detect environmental changes and release agents to prevent or mitigate fires. In food preservation, the canisters inhibit microorganism growth and extend shelf life.

Novelty and Inventive Step

The new claims introduce a paradigm shift in the application of nanoporous canister technology, moving from therapeutic agent delivery in humans to environmental sustainability and food preservation. The inventive step lies in the adaptation of the core technology to address distinct challenges in these new fields, thereby providing novel solutions with significant commercial potential.

Alternative Embodiments and Variations

Alternative embodiments may include variations in canister design, material selection, and biotherapeutic agent composition to optimize performance in different environmental and food preservation contexts. Additionally, the concept could be expanded to address other pressing challenges, such as climate change mitigation or sustainable energy solutions.

Potential Commercial Applications and Market

The nanoporous canister technology has vast commercial potential in various industries, including environmental monitoring and remediation, agriculture, water treatment, forestry, and food processing. The market size for these applications is substantial, with growing demand for innovative solutions to address pressing sustainability and food security challenges.

CPC Classifications

SectionClassGroup
A A61 A61K9/0024
A A61 A61F2/022
A A61 A61K31/337
A A61 A61K31/397
A A61 A61K31/436
A A61 A61K31/65
A A61 A61K31/7036
A A61 A61K35/28
A A61 A61K38/14
A A61 A61K38/1866
A A61 A61K38/22
A A61 A61K39/395
A A61 A61K47/02
A A61 A61M39/0247
A A61 A61M2039/027
A A61 A61M2039/0261
A A61 A61M2039/0276
A A61 A61M2205/04

Field of Art

Biomedical engineering, nanotechnology, and materials science with a focus on controlled delivery systems, particularly nanoporous structures for encapsulation and targeted agent release

Person of Ordinary Skill (PHOSITA) Profile

A skilled practitioner with advanced degrees in bioengineering or materials science, experienced in designing nanoscale delivery systems, familiar with material science principles, and capable of adapting technological platforms across different application domains

Obviousness Rationale

A PHOSITA would recognize the fundamental adaptability of the nanoporous canister technology from its original therapeutic context to environmental and preservation applications. The core technological principles of controlled agent release through nanoscale porous structures remain consistent across domains. The variations represent predictable extensions of the original patent's core technological concept by applying known encapsulation and controlled release mechanisms to alternative problem-solving contexts.

Obvious Combinations & Variations

Source Patent Element
Nanoscale through-porous structure with pores between 20-5000 nm for controlled agent diffusion
PTD Variation
Applying identical nanoporous structure to environmental monitoring and pollutant neutralization systems
Obviousness Reasoning
Predictable application of existing controlled release mechanism to a functionally analogous technical problem involving targeted agent deployment
Source Patent Element
Internal barrier for stabilizing metabolically active agents within the canister
PTD Variation
Using similar stabilization techniques for biotherapeutic agents in crop growth and food preservation contexts
Obviousness Reasoning
Known technique of agent encapsulation and controlled release can be directly translated across different substrate and application domains
Source Patent Element
Metallic shell configured for controlled secretion of metabolically active agents
PTD Variation
Adapting metallic nanoporous shell design for environmental monitoring and response systems
Obviousness Reasoning
Finite design solutions for controlled agent release are transferable across technological domains with minimal inventive complexity
Source Patent Element
Implantable device for isolating and diffusing therapeutic agents
PTD Variation
Reimagining implantation in soil, packaging, and environmental monitoring contexts
Obviousness Reasoning
Systematic design adaptation represents an obvious extension of the original technological platform using known engineering principles
Source Patent Element
Cellular and biotherapeutic agent delivery mechanism
PTD Variation
Expanding agent delivery to include environmental remediation and preservation agents
Obviousness Reasoning
Predictable technological evolution representing a straightforward application of existing controlled release principles to adjacent problem domains
35 U.S.C. § 103 Summary: Based on US Patent 11857670's teachings of nanoporous metallic canisters with controlled agent release mechanisms, the present publication demonstrates that the claimed variations represent obvious technological extensions readily apparent to a person having ordinary skill in the art, thereby establishing prior art that would render subsequent similar claims non-patentable under standard obviousness analysis.

Original Patent Information

Patent NumberUS 11,857,670
TitleImplantable cellular and biotherapeutic agent delivery canister
Assignee(s)NanoVault Medical LLC